— Know what they know.
Not Investment Advice

CABA NASDAQ

Cabaletta Bio, Inc.
1W: -3.4% 1M: -44.0% 3M: -33.5% YTD: -9.5% 1Y: -13.4% 3Y: -86.4% 5Y: -83.3%
$2.00
+0.11 (+5.82%)
 
Weekly Expected Move ±11.0%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 28 · $326.1M mcap · 143M float · 3.50% daily turnover · Short 43% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-10-11
Earliest Filing
2024-09-30
Latest Filing
partner: 2

Counterparties (Filed by CABA)

2 relationships

Companies named in CABA's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
CIC Innovation Communities, LLC — partner Amendment to Service Agreement for office and laboratory space lease 2024-09-30 View
Nanjing IASO Biotherapeutics Co., Ltd. — partner Exclusive license agreement for CD19 binder intellectual property 2022-10-11 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-14 Other Events View
2026-08-13 Earnings Release; Exhibits View
2026-06-11 Bylaws Amendment; Shareholder Vote; Exhibits View
2026-06-03 Regulation FD; Other Events; Exhibits View
2026-05-14 Earnings Release; Exhibits View
2026-05-14 Regulation FD; Other Events; Exhibits View
2026-05-04 Other Events; Exhibits View
2026-05-04 Material Agreement; Earnings Release; Other Events; Exhibits Agreement View
2026-04-20 Other Events; Exhibits View
2026-03-23 Earnings Release; Regulation FD; Exhibits View
2026-01-12 Regulation FD Disclosure; Other Events View
2025-11-10 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-29 Other Events; Financial Statements and Exhibits View
2025-10-27 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-10-09 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-09-03 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-12 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-06-11 Termination of Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Stat View
2025-06-10 Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms